Retatrutide (LY3437943) is a triple receptor agonist acting on the GLP-1, GIP, and glucagon receptors, studied in metabolic and obesity research for its effects on energy expenditure, glucose regulation and body composition
People who take the maximum dose of an injected GLP-1 drug can lose around 20 percent of their body weight, Tan notes much more than what this trial found for the maximum dose of the GLP-1 pill
Additionally, participants who engaged in both exercise and GLP-1 therapy saw greater improvements in body fat percentage and waist circumference, indicating better long term body composition maintenance
Theoretical (mechanistic): the HGF/c-Met pathway governs growth, proliferation, and angiogenesis and is dysregulated in some cancers, so chronic potentiation raises a theoretical oncological concern
This flood of NAD+ in the fat cells forces them to continuously burn energy rather than store it, leading to rapid reductions in fat mass without the need for dietary changes in animal models
in this strain, the apparent rise in cAP activity was larger, and the p value was smaller (0.20) but still in excess of the conventional line for statistical significance (Figure 3A)
